spec buy?, page-4

  1. 4,706 Posts.
    lightbulb Created with Sketch. 72
    Found this via the MKB threads

    "Grab a rising star, rather than a falling knife
    JOHN BEVERIDGE HERALD SUN OCTOBER 30, 2013 10:00PM

    "Another fast rising stock worth a second look is drug developer Invion.

    Run by former Chemgenex boss Dr Greg Collier and with a US clinical team led by prolific drug developer Dr Mitchell Glass, Invion has acquired rights to expand its range of potential treatments to asthma, chronic obstructive pulmonary disease, cystic fibrosis, lupus and smoking cessation.

    The toughest part in developing drugs is getting them past the US Food and Drug Administration so the combination of using some existing drugs repurposed for inhalation and an experienced team should fast track the clinical pathway.

    Invion shares have leapt since my first speculative buy in February but the call remains in place as phase two trials reduce risk and bring Invion closer to a deal with a major pharmaceutical partner."


    http://www.heraldsun.com.au/business/in-the-black/grab-a-rising-star-rather-than-a-falling-knife/story-fni0d787-1226750002908


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
10.5¢
Change
-0.005(4.55%)
Mkt cap ! $8.911M
Open High Low Value Volume
10.5¢ 11.0¢ 10.5¢ $4.784K 45.56K

Buyers (Bids)

No. Vol. Price($)
2 100263 10.5¢
 

Sellers (Offers)

Price($) Vol. No.
11.0¢ 70694 2
View Market Depth
Last trade - 15.32pm 21/07/2025 (20 minute delay) ?
IVX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.